Infusion-related thrombogenesis by liver-derived mesenchymal stem cells controlled by anticoagulant drugs in 11 patients with liver-based metabolic disorders.

HepaStem (heterologous human adult liver-derived mesenchymal stem cells) - Promethera Biosciences

Angiomax (bivalirudin) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/32028991

Feb 8, 2020